Mice treated with a combination of anti-PD-L1 and anti-PD-L2 showed robust proliferation of both OVA-specific TSL and Teff cells as anticipated (Fig. 5b,c and Extended Data Fig. 7c), as well as partial suppression of tumour growth (Extended Data Fig. 7a). This evidence concerns the gene CD274 and neoplasm.